ACUTE MONOCYTIC LEUKEMIA
Clinical trials for ACUTE MONOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE MONOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE MONOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for leukemia patients too frail for chemo?
Disease control Recruiting nowThis study tests a combination of three drugs (venetoclax, azacytidine, and chidamide) for people newly diagnosed with a specific type of leukemia called acute monocytic leukemia who are not healthy enough for standard intensive chemotherapy. The goal is to see if this drug combo…
Matched conditions: ACUTE MONOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 17, 2026 00:46 UTC
-
New leukemia combo shows promise in early trial
Disease control Recruiting nowThis study compares a new treatment (venetoclax plus CACAG chemo) to the standard 3+7 chemo for people with acute monocytic leukemia. About 204 patients aged 14-60 will take part. The goal is to see if the new combo leads to more complete remissions after one cycle of treatment.
Matched conditions: ACUTE MONOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for Hard-to-Treat leukemias: first human trial begins
Disease control Recruiting nowThis early-stage study tests a new drug called STX-0712 in people with advanced types of leukemia (CMML or AML) that have not responded to other treatments. The main goals are to find a safe dose and check for side effects. About 105 adults will take part in this first-in-human t…
Matched conditions: ACUTE MONOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Solu Therapeutics, Inc • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Promising new combo targets hard-to-treat leukemia
Disease control Recruiting nowThis study tests a new combination of drugs for people newly diagnosed with a specific type of acute myeloid leukemia (AML). The treatment uses venetoclax, which blocks a protein that helps cancer cells survive, along with three chemotherapy drugs. The goal is to see if this comb…
Matched conditions: ACUTE MONOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 13, 2026 15:59 UTC